These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25830485)

  • 1. Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.
    Diness JG; Bentzen BH; Sørensen US; Grunnet M
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):441-8. PubMed ID: 25830485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
    Nattel S; Dobrev D
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We?
    El-Haou S; Ford JW; Milnes JT
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):412-31. PubMed ID: 25978691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
    Hanley CM; Robinson VM; Kowey PR
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial-selective K
    Ravens U
    Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of atrial fibrillation: future directions.
    Page RL
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti-arrhythmic drugs for atrial fibrillation management.
    Ehrlich JR; Nattel S; Hohnloser SH
    Curr Vasc Pharmacol; 2007 Jul; 5(3):185-95. PubMed ID: 17627562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
    Diness JG; Sørensen US; Nissen JD; Al-Shahib B; Jespersen T; Grunnet M; Hansen RS
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):380-90. PubMed ID: 20562443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.
    Skibsbye L; Diness JG; Sørensen US; Hansen RS; Grunnet M
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):672-81. PubMed ID: 21394037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
    Haugaard MM; Hesselkilde EZ; Pehrson S; Carstensen H; Flethøj M; Præstegaard KF; Sørensen US; Diness JG; Grunnet M; Buhl R; Jespersen T
    Heart Rhythm; 2015 Apr; 12(4):825-35. PubMed ID: 25542425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation.
    Nattel S
    J Physiol; 2009 Apr; 587(Pt 7):1385-6. PubMed ID: 19336611
    [No Abstract]   [Full Text] [Related]  

  • 14. Small-conductance Ca2+ -activated K+ channels and cardiac arrhythmias.
    Zhang XD; Lieu DK; Chiamvimonvat N
    Heart Rhythm; 2015 Aug; 12(8):1845-51. PubMed ID: 25956967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: Therapeutic potential of atrial K
    Ravens U; Odening KE
    Pharmacol Ther; 2017 Aug; 176():13-21. PubMed ID: 27742566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
    Diness JG; Skibsbye L; Jespersen T; Bartels ED; Sørensen US; Hansen RS; Grunnet M
    Hypertension; 2011 Jun; 57(6):1129-35. PubMed ID: 21502564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation.
    Podd SJ; Freemantle N; Furniss SS; Sulke N
    Europace; 2016 Mar; 18(3):340-6. PubMed ID: 26462707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic Effect of Either Negative Modulation or Blockade of Small Conductance Ca2+-activated K+ Channels on Ventricular Fibrillation in Guinea Pig Langendorff-perfused Heart.
    Diness JG; Kirchhoff JE; Sheykhzade M; Jespersen T; Grunnet M
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):294-9. PubMed ID: 25978690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effect of the Ca
    Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
    Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.